161 related articles for article (PubMed ID: 24007794)
1. Drug transport via the intestinal peptide transporter PepT1.
Brandsch M
Curr Opin Pharmacol; 2013 Dec; 13(6):881-7. PubMed ID: 24007794
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical and pharmacological importance of peptide transporters.
Brandsch M; Knütter I; Bosse-Doenecke E
J Pharm Pharmacol; 2008 May; 60(5):543-85. PubMed ID: 18416933
[TBL] [Abstract][Full Text] [Related]
3. Thiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery.
Foley DW; Pathak RB; Phillips TR; Wilson GL; Bailey PD; Pieri M; Senan A; Meredith D
Eur J Med Chem; 2018 Aug; 156():180-189. PubMed ID: 30006163
[TBL] [Abstract][Full Text] [Related]
4. Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.
Brodin B; Nielsen CU; Steffansen B; Frøkjaer S
Pharmacol Toxicol; 2002 Jun; 90(6):285-96. PubMed ID: 12403049
[TBL] [Abstract][Full Text] [Related]
5. Peptide transporters: structure, function, regulation and application for drug delivery.
Terada T; Inui K
Curr Drug Metab; 2004 Feb; 5(1):85-94. PubMed ID: 14965252
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
[TBL] [Abstract][Full Text] [Related]
7. Expression, regulation and function of intestinal drug transporters: an update.
Müller J; Keiser M; Drozdzik M; Oswald S
Biol Chem; 2017 Feb; 398(2):175-192. PubMed ID: 27611766
[TBL] [Abstract][Full Text] [Related]
8. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
9. Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
Brandsch M
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):887-905. PubMed ID: 19519280
[TBL] [Abstract][Full Text] [Related]
10. The in vitro transport of model thiodipeptide prodrugs designed to target the intestinal oligopeptide transporter, PepT1.
Foley D; Pieri M; Pettecrew R; Price R; Miles S; Lam HK; Bailey P; Meredith D
Org Biomol Chem; 2009 Sep; 7(18):3652-6. PubMed ID: 19707666
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
12. Targeted prodrugs in oral drug delivery: the modern molecular biopharmaceutical approach.
Dahan A; Khamis M; Agbaria R; Karaman R
Expert Opin Drug Deliv; 2012 Aug; 9(8):1001-13. PubMed ID: 22703376
[TBL] [Abstract][Full Text] [Related]
13. [Molecular characteristics and tissue distribution of peptide transporters].
Han F; Le GW; Shi YH
Sheng Li Ke Xue Jin Zhan; 2003 Jul; 34(3):222-6. PubMed ID: 14628467
[TBL] [Abstract][Full Text] [Related]
14. Intestinal uptake of nateglinide by an intestinal fluorescein transporter.
Itagaki S; Otsuka Y; Kubo S; Okumura H; Saito Y; Kobayashi M; Hirano T; Iseki K
Biochim Biophys Acta; 2005 Mar; 1668(2):190-4. PubMed ID: 15737329
[TBL] [Abstract][Full Text] [Related]
15. In Vitro and Clinical Evaluations of the Drug-Drug Interaction Potential of a Metabotropic Glutamate 2/3 Receptor Agonist Prodrug with Intestinal Peptide Transporter 1.
Pak YA; Long AJ; Annes WF; Witcher JW; Knadler MP; Ayan-Oshodi MA; Mitchell MI; Leese P; Hillgren KM
Drug Metab Dispos; 2017 Feb; 45(2):137-144. PubMed ID: 27895114
[TBL] [Abstract][Full Text] [Related]
16. OATP transporter-mediated drug absorption and interaction.
Tamai I; Nakanishi T
Curr Opin Pharmacol; 2013 Dec; 13(6):859-63. PubMed ID: 24060700
[TBL] [Abstract][Full Text] [Related]
17. Stereoselectivity of chiral drug transport: a focus on enantiomer-transporter interaction.
Zhou Q; Yu LS; Zeng S
Drug Metab Rev; 2014 Aug; 46(3):283-90. PubMed ID: 24796860
[TBL] [Abstract][Full Text] [Related]
18. The importance of drug transporter characterization to precision medicine.
Fisel P; Nies AT; Schaeffeler E; Schwab M
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):361-365. PubMed ID: 28140687
[No Abstract] [Full Text] [Related]
19. [Improvement of intestinal absorption of drugs by activating peptide transporter PEPT1 by acidic polymers].
Nozawa T; Tamai I
Nihon Yakurigaku Zasshi; 2005 Apr; 125(4):194-9. PubMed ID: 15930795
[No Abstract] [Full Text] [Related]
20. Intestinal drug transporters in pathological states: an overview.
Drozdzik M; Czekawy I; Oswald S; Drozdzik A
Pharmacol Rep; 2020 Oct; 72(5):1173-1194. PubMed ID: 32715435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
